I want to thank the honourable member for that question. Maybe I'll start answering where she left off.
We understand—and we share this with everybody on all sides of the House—the absolute urgency for Canadians to have access to life-saving vaccines and to make sure that they are readily available. This is the sense of urgency the government works with every single day, including me, all of my colleagues and the Prime Minister.
With more than 1.1 million vaccines distributed across the country to date, Canada is among the top five G20 nations for COVID-19 vaccines. We are on track to receive six million vaccines by the end of Q1, 20 million between April and June, and a total of 70 million doses by the end of September. That is just with the approved vaccines alone. Our government continues to stay on top of this.
The advance purchase agreement is noted in the EU's announcement. The regulation is clear in respect of APAs that have already been contracted by third countries, such as Canada. In the conversation I had with my counterpart, on two occasions—as well as the Prime Minister with President von der Leyen, and the health minister with the commissioner of health in the EU—we received repeated assurances that Canada's vaccine shipments will not be affected by this measure.
Having said that, we take this very seriously. We will continue to work on this here. The team Canada that is on the ground for the missions in Europe continues to work with the companies as well as the member states and the European Union to ensure there is no disruption.